Clinical ResearchCardiac Resynchronization TherapyReduction of the Risk of Recurring Heart Failure Events With Cardiac Resynchronization Therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)
Cardiac Resynchronization Therapy
Under an Elsevier user license
open archive
Key Words
cardiac resynchronization therapy
heart failure
mortality
Abbreviations and Acronyms
CI
confidence interval
CRT
cardiac resynchronization therapy
CRT-D
cardiac resynchronization therapy-defibrillator
HFE
heart failure event
HR
hazard ratio
ICD
implantable cardioverter-defibrillator
ITT
intention to treat
LBBB
left bundle branch block
NYHA
New York Heart Association
Cited by (0)
The MADIT-CRT trial was supported by a research grant from Boston Scientific Corp., St. Paul, Minnesota, to the University of Rochester School of Medicine and Dentistry. Drs. Moss, Hall, and Zareba have received research support for the conduct of the MADIT-CRT trial from Boston Scientific through a grant to the University of Rochester. All other authors have reported that they have no relationships to disclose. Drs. Goldenberg and Hall contributed equally to this work.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.